Replies to post #282 on Opexa Therapeutics, Inc. (OPXA)

[tnzalu]

Hey there Kei. I'm hopeful getting a green light for P3 trial (and certain plans 'firmed') is the milestone needed to cement a commercial partnership with progressive tranches of funding through P3, to solve the cash problem. Regarding the funding of ongoing (non-P3) operations, it would seem imprudent to me if OPXA hadn't sold some shares into the strength we've seen since the FDA press release.

[kei]

see what i meant...

cash; 4.73 m
debt; 52.92 k
cash burn rate is 2 m per quarter

my concern is they don't look like they have enough cash.



and opxa is ready to go with money :)